We obtained analogous results using the BRCA2-deficient (Brca2-/-) mouse mammary tumor cell line KB2P (clone 1.2129), confirming that treatment with IFNβ did not restore RAD51 foci (Supplementary Fig. 3d–f). This evidence concerns the gene BRCA2 and breast cancer.